Nuclear factor kappa B signaling in catabolic disorders

被引:16
作者
Holmes-McNary, M [1 ]
机构
[1] Ohio State Univ, Coll Human Ecol & Med, Dept Human Nutr, Ctr Comprehens Canc, Columbus, OH 43210 USA
关键词
D O I
10.1097/00075197-200205000-00004
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The nuclear factor kappaB family of inducible transcription factors regulates the expression of many genes. Nuclear factor kappaB has been implicated in autoimmune and inflammatory diseases, infection, cell survival, and cell transformation with subsequent promotion of cancer. In this review, we summarize features of nuclear factor kappaB regulation in several catabolic disorders, and describe its role in normal cellular function as well as provide an important link to the role of scaffold proteins, cellular receptors, and other cell signaling pathway kinases that converge on the nuclear factor kappaB signaling cascade. Subsequently, we focus on the role of nuclear factor kappaB in cell survival and oxidative stress. Finally, potential therapeutic strategies are discussed that may modify nuclear factor kappaB activity including endogenous antioxidant systems and the Fas/FasL system. However, challenges still remain in developing new therapeutic strategies that not only include identifying novel agents, but also by improving clinical endpoint definitions and by defining biological efficacy. (C) 2002 Lippincott Williams Wilkins.
引用
收藏
页码:255 / 263
页数:9
相关论文
共 57 条
[21]   Dehydration activates an NF-κB-driven, COX2-dependent survival mechanism in renal medullary interstitial cells [J].
Hao, CM ;
Yull, F ;
Blackwell, T ;
Kömhoff, M ;
Davis, LS ;
Breyer, MD .
JOURNAL OF CLINICAL INVESTIGATION, 2000, 106 (08) :973-982
[22]   The mitochondrial permeability transition augments Fas-induced apoptosis in mouse hepatocytes [J].
Hatano, E ;
Bradham, CA ;
Stark, A ;
Iimuro, Y ;
Lemasters, JJ ;
Brenner, DA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (16) :11814-11823
[23]   Distinct roles of thioredoxin in the cytoplasm and in the nucleus -: A two-step mechanism of redox regulation of transcription factor NF-κB [J].
Hirota, K ;
Murata, M ;
Sachi, Y ;
Nakamura, H ;
Takeuchi, J ;
Mori, K ;
Yodoi, J .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (39) :27891-27897
[24]  
Holmes-McNary M, 2000, CANCER RES, V60, P3477
[25]   Opposing regulation of choline deficiency-induced apoptosis by p53 and nuclear factor κB. [J].
Holmes-McNary, MQ ;
Baldwin, AS ;
Zeisel, SH .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (44) :41197-41204
[26]   Lipopolysaccharide recognition, CD14, and lipopolysaccharide receptors [J].
Ingalls, RR ;
Heine, H ;
Lien, E ;
Yoshimura, A ;
Golenbock, D .
INFECTIOUS DISEASE CLINICS OF NORTH AMERICA, 1999, 13 (02) :341-+
[27]  
Inohara N, 2000, J BIOL CHEM, V275, P27823
[28]   Inhibition of NF-κB sensitizes non-small cell lung cancer cells to chemotherapy-induced apoptosis [J].
Jones, DR ;
Broad, RM ;
Madrid, LV ;
Baldwin, AS ;
Mayo, MW .
ANNALS OF THORACIC SURGERY, 2000, 70 (03) :930-936
[29]   Phosphorylation meets ubiquitination:: The control of NF-κB activity [J].
Karin, M ;
Ben-Neriah, Y .
ANNUAL REVIEW OF IMMUNOLOGY, 2000, 18 :621-+
[30]   Thyrotropin modifies activation of nuclear factor κB by tumour necrosis factor α in rat thyroid cell line [J].
Kikumori, T ;
Kambe, F ;
Nagaya, T ;
Funahashi, H ;
Seo, H .
BIOCHEMICAL JOURNAL, 2001, 354 (354) :573-579